CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Veropharm AO is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Veropharm AO
Barabannyi per. 3
Phone: +7 4957925330p:+7 4957925330 MOSCOW, 107023  Russian Federation Fax: +7 4957925328f:+7 4957925328
This company was Merged or Acquired on 12/12/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Veropharm AO (Verofarm AO or Veropharm JSC), formerly Veropharm PAO and Veropharm OAO, is a Russia-based generic pharmaceutical manufacturer. It has two main facilities: in Voronezh, which manufactures adhesive bandages and medical plasters and in Belgorod, which is engaged in the ready-made medications such as tablets. The Company has five subsidiaries located in the Russian Federation, Ukraine, Kazakhstan and Cyprus. Verofarm AO sells its products on the domestic market, as well as exports them to Serbia, Montenegro, Latvia, Lithuania, Estonia and the Commonwealth of Independent States (CIS) countries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201412/31/2013Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairwoman of the Board Elena O.Kartasheva 12/22/2014 11/1/2014
General Director Elena Y.Bushberg 2/28/2015 2/28/2015
Director Georges H.De Vos 56 12/1/2014 12/1/2014
4 additional Officers and Directors records available in full report.

General Information
Stock Exchange: MCX
Fax Number: +7 4957925328


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 23, 2023